佐剂
免疫系统
耐受性
脂质A
抗原
受体
化学
先天免疫系统
抗体
免疫原性
纳米颗粒
免疫增强剂
免疫学
纳米技术
免疫
生物物理学
细胞生物学
固体脂质纳米粒
疫苗佐剂
生物
模式识别受体
CpG寡核苷酸
免疫
材料科学
药物输送
脂质信号
作者
Haolin Chen,Ruifeng Wang,Zhihui Zhang,Zeyu Yang,Zhenfu Wen,Liyan Li,Zhijia Liu,Dang Fan,Yuhua Xu,Ming Li,Hong Liu,Lixin Liu,Yongming Chen
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-08-21
卷期号:20 (34): 24004-24019
标识
DOI:10.1021/acsnano.6c09358
摘要
Vaccines rely on adjuvants to stimulate the immune system, but achieving strong immune activation together with acceptable tolerability remains a major challenge. Lipid nanoparticles are widely used as delivery platforms, yet how their internal organization can be engineered to coordinate multiple innate immune signals remains poorly understood. Here, we designed a hybrid lipid nanoparticle adjuvant that coformulates two clinically relevant immune stimulators targeting toll-like receptor 4 (TLR4) and TLR9. By blending two ionizable lipids, the nanoparticles self-assemble into a layered structure with a raft-associated ordered outer shell and an inner core, with apparent enrichment of monophosphoryl lipid A (MPLA) toward the particle surface and CpG toward the interior, as suggested by our experimental and simulation analyses. This organization is consistent with a relay-like activation pattern that may contribute to strong immune responses while potentially reducing early inflammatory reactions. The hybrid adjuvant enhances antibody quality, cellular immunity, and protective efficacy under the tested conditions, across multiple vaccine antigens and animal models, with performance comparable to or exceeding benchmark adjuvants. These findings suggest that controlling nanoscale lipid organization provides a useful strategy for improving vaccine adjuvant performance.
科研通智能强力驱动
Strongly Powered by AbleSci AI